Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.27B |
| 2 |
Zimmer Biomet
ZBH
|
+$3.42B |
| 3 |
TransUnion
TRU
|
+$1.8B |
| 4 |
Qualcomm
QCOM
|
+$587M |
| 5 |
Alibaba
BABA
|
+$434M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$1.06B |
| 2 |
Pfizer
PFE
|
+$895M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$631M |
| 4 |
RTX Corp
RTX
|
+$546M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$516M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 8.41% |
| 2 | Healthcare | 8.04% |
| 3 | Technology | 7.66% |
| 4 | Energy | 6.94% |
| 5 | Consumer Discretionary | 6.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4276
CALL
Sherwin-Williams
SHW
$82.7B
| $1.24M | ﹤0.01% |
13,500
-300
| -2% | -$28.4K |
|
4277
ProShares Ultra Industrials
UXI
$31M
| $1.24M | ﹤0.01% |
130,404
-1,704
| -1% | -$17K |
|
4278
CALL
Southern Copper
SCCO
$143B
| $1.24M | ﹤0.01% |
45,306
-16,612
| -27% | -$475K |
|
|
CRAY
4279
DELISTED
Cray, Inc.
CRAY
| $1.24M | ﹤0.01% |
41,863
-14,960
| -26% | -$453K |
|
4280
CALL
Opko Health
OPK
$985M
| $1.23M | ﹤0.01% |
76,700
-58,400
| -43% | -$908K |
|
4281
PUT
Parker-Hannifin
PH
$123B
| $1.23M | ﹤0.01% |
10,600
-25,900
| -71% | -$3.13M |
|
|
LXK
4282
CALL
DELISTED
Lexmark Intl Inc
LXK
| $1.23M | ﹤0.01% |
27,900
-48,400
| -63% | -$2.15M |
|
|
GOGL
4283
DELISTED
Golden Ocean Group
GOGL
| $1.23M | ﹤0.01% |
+64,002
| New | +$1.47M |
|
|
MRNS
4284
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $1.23M | ﹤0.01% |
26,547
+22,378
| +537% | +$836K |
|
|
MLNX
4285
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $1.23M | ﹤0.01% |
25,349
+2,736
| +12% | +$133K |
|
|
BMCH
4286
DELISTED
BMC Stock Holdings, Inc
BMCH
| $1.23M | ﹤0.01% |
62,859
+11,362
| +22% | +$213K |
|
4287
Box
BOX
$4.37B
| $1.23M | ﹤0.01% |
65,807
-110,445
| -63% | -$1.94M |
|
|
RWT
4288
Redwood Trust
RWT
$574M
| $1.23M | ﹤0.01% |
78,137
-99,501
| -56% | -$1.69M |
|
4289
Brink's
BCO
$4.88B
| $1.22M | ﹤0.01% |
41,589
+16,003
| +63% | +$484K |
|
4290
Inovio Pharmaceuticals
INO
$55.7M
| $1.22M | ﹤0.01% |
12,477
+533
| +4% | +$56.9K |
|
4291
CALL
Insmed
INSM
$21.4B
| $1.22M | ﹤0.01% |
+50,000
| New | +$1.14M |
|
|
4292
PUT
Insmed
INSM
$21.4B
| $1.22M | ﹤0.01% |
+50,000
| New | +$1.14M |
|
|
NAV
4293
PUT
DELISTED
Navistar International
NAV
| $1.22M | ﹤0.01% |
53,900
+36,200
| +205% | +$990K |
|
|
KEM
4294
DELISTED
KEMET Corporation
KEM
| $1.22M | ﹤0.01% |
423,678
+401,356
| +1,798% | +$1.47M |
|
4295
Churchill Downs
CHDN
$5.88B
| $1.22M | ﹤0.01% |
58,488
+38,574
| +194% | +$779K |
|
4296
Innospec
IOSP
$2.12B
| $1.22M | ﹤0.01% |
27,043
+405
| +2% | +$18.2K |
|
|
SEE
4297
PUT
DELISTED
Sealed Air
SEE
| $1.22M | ﹤0.01% |
23,700
-1,500
| -6% | -$72.1K |
|
|
GNCMA
4298
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $1.22M | ﹤0.01% |
71,613
-829
| -1% | -$13.5K |
|
|
DCH
4299
CALL
Dauch Corp
DCH
$1.34B
| $1.22M | ﹤0.01% |
58,200
-97,500
| -63% | -$2.35M |
|
|
FIT
4300
PUT
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $1.22M | ﹤0.01% |
+31,800
| New | +$1.12M |
|
Similar funds
Goldman Sachs's Q2 2015 Portfolio in Review
As of Q2 2015, Goldman Sachs held 7,731 positions worth $323B, up 3.7% from $311B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Goldman Sachs deployed $13.1B of net new capital in Q2 2015, opening 673 new positions and adding to 3,224 existing holdings. Its largest new stake was TransUnion: 72,355,340 shares worth $1.82B.
By sector, the portfolio is most concentrated in Financials at 8.4% of assets, up from 8% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Gilead Sciences, an estimated $1.06B trimmed.
- Goldman Sachs's largest Q2 2015 buy was TransUnion: 72,355,340 shares worth $1.82B.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $4.27B increase.
- Goldman Sachs's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $1.06B.
- Goldman Sachs fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $386M.
- Goldman Sachs's ten largest holdings make up 14% of its $323B portfolio in Q2 2015.
- Goldman Sachs opened 673 new positions and closed 497 in Q2 2015.
- Goldman Sachs's portfolio value rose 3.7% quarter-over-quarter to $323B.
Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.